Leptin in the interplay of inflammation, metabolism and immune system disorders

Nature Reviews Rheumatology

Volumn 13, Issue 2, 2017, Pages 100-109

  Abella, Vanessa ^a   Scotece, Morena ^a   Conde, Javier ^a   Pino, Jesús ^a   Gonzalez Gay, Miguel Angel ^b   Gómez Reino, Juan J ^a   Mera, Antonio ^a   Lago, Francisca ^a   Gómez, Rodolfo ^a   Gualillo, Oreste ^a  

^a University Hospital of Santiago de Compostela   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; LEPTIN RECEPTOR;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; BASOPHIL; CELL FUNCTION; DENDRITIC CELL; EOSINOPHIL; HUMAN; IMMUNE DEFICIENCY; IMMUNOREGULATION; INFLAMMATION; MACROPHAGE; METABOLISM; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; OSTEOARTHRITIS; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; ANIMAL; IMMUNOPATHOLOGY; INNATE IMMUNITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNITY, INNATE; INFLAMMATION; KILLER CELLS, NATURAL; LEPTIN; NEUTROPHILS; OSTEOARTHRITIS; RECEPTORS, LEPTIN;

EID: 85008312137     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2016.209     Document Type: Review

References (133)

1. Zhang Y, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432 (1994).
2. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115, 911-919 (2005).
3. Hotamisligil G. S, Shargill N. S, & Spiegelman B. M. Adipose expression of tumor necrosis factor-Alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91 (1993).
4. Fantuzzi G, & Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J. Leukoc. Biol. 68, 437-446 (2000).
5. Lago F, Dieguez C, Gómez-Reino J, & Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat. Clin. Pract. Rheumatol. 3, 716-724 (2007).
6. Otero M, Lago R, Lago F, Reino J. J. G, & Gualillo O. Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin 1. Arthritis Res. Ther. 7, 581-591 (2005).
7. Tilg H, & Moschen A. R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 772-783 (2006).
8. Lago F, Gómez R, Gómez-Reino J. J, Dieguez C, & Gualillo O. Adipokines as novel modulators of lipid metabolism. Trends Biochem. Sci. 34, 500-510 (2009).
9. Lago F, Dieguez C, Gómez-Reino J, & Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 18, 313-325 (2007).
10. Frühbeck G. Intracellular signalling pathways activated by leptin. Biochem. J. 393, 7-20 (2006).
11. Procaccini C, Jirillo E, & Matarese G. Leptin as an immunomodulator. Mol. Aspects Med. 33, 35-45 (2012).
12. Carlton E. D, Demas G. E, & French S. S. Leptin, a neuroendocrine mediator of immune responses, inflammation, and sickness behaviors. Horm. Behav. 62, 272-279 (2012).
13. La Cava A, & Matarese G. The weight of leptin in immunity. Nat. Rev. Immunol. 4, 371-379 (2004).
14. Rosenbaum M, & Leibel R. L. 20 years of leptin: role of leptin in energy homeostasis in humans. J. Endocrinol. 223, T83-T96 (2014).
15. Di Carlo C, Tommaselli G. A, & Nappi C. Effects of sex steroid hormones and menopause on serum leptin concentrations. Gynecol. Endocrinol. 16, 479-491 (2002).
16. Gualillo O, Eiras S, Lago F, Diéguez C, & Casanueva F. F. Elevated serum leptin concentrations induced by experimental acute inflammation. Life Sci. 67, 2433-2441 (2000).
17. Behnes M, et al. Alterations of leptin in the course of inflammation and severe sepsis. BMC Infect. Dis. 12, 217 (2012).
18. Feijóo-Bandín S, et al. 20 years of leptin: role of leptin in cardiomyocyte physiology and physiopathology. Life Sci. 140, 10-18 (2015).
19. Chou S. H, & Mantzoros C. 20 years of leptin: role of leptin in human reproductive disorders. J. Endocrinol. 223, T49-62 (2014).
20. Conde J, et al. An update on leptin as immunomodulator. Expert Rev. Clin. Immunol. 10, 1165-1170 (2014).
21. Scotece M, et al. Adipokines as drug targets in joint and bone disease. Drug Discov. Today http://dx.doi. org/10.1016/j.drudis.2013.07.012 (2013).
22. Gez R, et al. What?s new in our understanding of the role of adipokines in rheumatic diseases?. Nat. Rev. Rheumatol. 7, 528-536 (2011).
23. Edwards C, et al. The effects of bariatric surgery weight loss on knee pain in patients with osteoarthritis of the knee. Arthritis 2012, 504189 (2012).
24. Wluka A. E, Lombard C. B, & Cicuttini F. M. Tackling obesity in knee osteoarthritis. Nat. Rev. Rheumatol. 9, 225-235 (2013).
25. Yusuf E, et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann. Rheum. Dis. 69, 761-765 (2010).
26. Grotle M, Hagen K. B, Natvig B, Dahl F. A, & Kvien T. K. Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow up. BMC Musculoskelet. Disord. 9, 132 (2008).
27. Sakkas L. I, et al. T cells and T cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin. Diagn. Lab. Immunol. 5, 430-437 (1998).
28. Nakamura H, Yoshino S, Kato T, Tsuruha J, & Nishioka K. T cell mediated inflammatory pathway in osteoarthritis. Osteoarthritis Cartilage 7, 401-402 (1999).
29. Ishii H, et al. Characterization of infiltrating T cells and Th1/Th2 type cytokines in the synovium of patients with osteoarthritis. Osteoarthritis Cartilage 10, 277-281 (2002).
30. Tian Z, Sun R, Wei H, & Gao B. Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem. Biophys. Res. Commun. 298, 297-302 (2002).
31. Zhao Y, Sun R, You L, Gao C, & Tian Z. Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem. Biophys. Res. Commun. 300, 247-252 (2003).
32. Nave H, et al. Resistance of Janus kinase 2 dependent leptin signaling in natural killer (NK) cells: a novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology 149, 3370-3378 (2008).
33. Lo C. K. C, et al. Leptin signaling protects NK cells from apoptosis during development in mouse bone marrow. Cell. Mol. Immunol. 6, 353-360 (2009).
34. Laue T, et al. Altered NK cell function in obese healthy humans. BMC Obes. 2, 1 (2015).
35. Wrann C. D, et al. Short-Term and long-Term leptin exposure differentially affect human natural killer cell immune functions. Am. J. Physiol. Endocrinol. Metab. 302, E108-E116 (2012).
36. Lamas B, et al. Leptin modulates dose-dependently the metabolic and cytolytic activities of NK 92 cells. J. Cell. Physiol. 228, 1202-1209 (2013).
37. Jahn J, et al. Decreased NK cell functions in obesity can be reactivated by fat mass reduction. Obes. (Silver Spring). 23, 2233-2241 (2015).
38. Caldefie-Chezet F, Poulin A, Tridon A, Sion B, & Vasson M. P. Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action?. J. Leukoc. Biol. 69, 414-418 (2001).
39. Zarkesh-Esfahani H, et al. Leptin indirectly activates human neutrophils via induction of TNF-α. J. Immunol. 172, 1809-1814 (2004).
40. Bjorbaek C, Uotani S, da Silva B, & Flier J. S. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem. 272, 32686-32695 (1997).
41. Caldefie-Chezet F, Poulin A, & Vasson M. P. Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic. Res. 37, 809-814 (2003).
42. Montecucco F, et al. Induction of neutrophil chemotaxis by leptin: crucial role for p38 and Src kinases. Ann. NY Acad. Sci. 1069, 463-471 (2006).
43. Bruno A, Conus S, Schmid I, & Simon H. U. Apoptotic pathways are inhibited by leptin receptor activation in neutrophils. J. Immunol. 174, 8090-8096 (2005).
44. Sun Z, Dragon S, Becker A, & Gounni A. S. Leptin inhibits neutrophil apoptosis in children via ERK/.NF ?B dependent pathways. PLoS ONE 8, e55249 (2013).
45. Kamp V. M, et al. Physiological concentrations of leptin do not affect human neutrophils. PLoS ONE 8, e73170 (2013).
46. do Carmo L. S, et al. A high-fat diet increases interleukin 3 and granulocyte colony-stimulating factor production by bone marrow cells and triggers bone marrow hyperplasia and neutrophilia in Wistar rats. Exp. Biol. Med. (Maywood). 238, 375-384 (2013).
47. Brotfain E, et al. Neutrophil functions in morbidly obese subjects. Clin. Exp. Immunol. 181, 156-163 (2015).
48. Conus S, Bruno A, & Simon H. U. Leptin is an eosinophil survival factor. J. Allergy Clin. Immunol. 116, 1228-1234 (2005).
49. Kato H, et al. Leptin has a priming effect on eotaxin-induced human eosinophil chemotaxis. Int. Arch. Allergy Immunol. 155, 335-344 (2011).
50. Wong C. K, Cheung P. F. Y, & Lam C. W. K. Leptin-mediated cytokine release and migration of eosinophils: implications for immunopathophysiology of allergic inflammation. Eur. J. Immunol. 37, 2337-2348 (2007).
51. Suzukawa M, et al. Leptin enhances survival and induces migration, degranulation, and cytokine synthesis of human basophils. J. Immunol. 186, 5254-5260 (2011).
52. Tsiotra P. C, Pappa V, Raptis S. A, & Tsigos C. Expression of the long and short leptin receptor isoforms in peripheral blood mononuclear cells: implications for leptin?s actions. Metabolism. 49, 1537-1541 (2000).
53. O?Rourke L, Yeaman S. J, & Shepherd P. R. Insulin and leptin acutely regulate cholesterol ester metabolism in macrophages by novel signaling pathways. Diabetes 50, 955-961 (2001).
54. Santos-Alvarez J, Goberna R, & Schez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell. Immunol. 194, 6-11 (1999).
55. Conde J, et al. At the crossroad between immunity and metabolism: focus on leptin. Expert Rev. Clin. Immunol. 6, 801-808 (2010).
56. Gutierrez D. A, & Hasty A. H. Haematopoietic leptin receptor deficiency does not affect macrophage accumulation in adipose tissue or systemic insulin sensitivity. J. Endocrinol. 212, 343-351 (2012).
57. Tsiotra P. C, Boutati E, Dimitriadis G, & Raptis S. A. High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells. Biomed. Res. Int. 2013, 487081 (2013).
58. Jitprasertwong P, Jaedicke K. M, Nile C. J, Preshaw P. M, & Taylor J. J. Leptin enhances the secretion of interleukin (IL)-18, but not IL 1β, from human monocytes via activation of caspase 1. Cytokine 65, 222-230 (2014).
59. Gez R, Villalvilla A, Largo R, Gualillo O, & Herrero-Beaumont G. TLR4 signalling in osteoarthritis-finding targets for candidate DMOADs. Nat. Rev. Rheumatol. 11, 159-170 (2015).
60. Jaedicke K. M, et al. Leptin up regulates TLR2 in human monocytes. J. Leukoc. Biol. 93, 561-571 (2013).
61. Acedo S. C, Gambero S, Cunha F. G. P, Lorand-Metze I, & Gambero A. Participation of leptin in the determination of the macrophage phenotype: an additional role in adipocyte and macrophage crosstalk. In Vitro Cell. Dev. Biol. Anim. 49, 473-478 (2013).
62. Luan B, et al. Leptin-mediated increases in catecholamine signaling reduce adipose tissue inflammation via activation of macrophage HDAC4. Cell Metab. 19, 1058-1065 (2014).
63. Zhou Y, et al. Leptin deficiency shifts mast cells toward anti-inflammatory actions and protects mice from obesity and diabetes by polarizing M2 macrophages. Cell Metab. 22, 1045-1058 (2015).
64. Munoz L. E, et al. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 17, 371-375 (2008).
65. Amarilyo G, Iikuni N, Liu A, Matarese G, & La Cava A. Leptin enhances availability of apoptotic cell-derived self-Antigen in systemic lupus erythematosus. PLoS ONE 9, e112826 (2014).
66. Okano T, et al. Hyperleptinemia suppresses aggravation of arthritis of collagen-Antibody-induced arthritis in mice. J. Orthop. Sci. 20, 1106-1113 (2015).
67. Voloshyna I, Mounessa J, Carsons S. E, & Reiss A. B. Effect of inhibition of interleukin 12/23 by ustekinumab on the expression of leptin and leptin receptor in human THP 1 macrophages. Clin. Exp. Dermatol. 41, 308-311 (2016).
68. Dib L. H, Ortega M. T, Melgarejo T, & Chapes S. K. Establishment and characterization of DB 1: a leptin receptor-deficient murine macrophage cell line. Cytotechnology http://dx.doi.org/10.1007/.s10616 015 9843 3 (2015).
69. Mattioli B, Straface E, Quaranta M. G, Giordani L, & Viora M. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J. Immunol. 174, 6820-6828 (2005).
70. Lam Q. L. K, Liu S, Cao X, & Lu L. Involvement of leptin signaling in the survival and maturation of bone marrow-derived dendritic cells. Eur. J. Immunol. 36, 3118-3130 (2006).
71. Mattioli B, Giordani L, Quaranta M. G, & Viora M. Leptin exerts an anti-Apoptotic effect on human dendritic cells via the PI3K Akt signaling pathway. FEBS Lett. 583, 1102-1106 (2009).
72. Al Hassi H. O, et al. A mechanistic role for leptin in human dendritic cell migration: differences between ileum and colon in health and Crohn?s disease. Mucosal Immunol. 6, 751-761 (2013).
73. Mattioli B, et al. Leptin as an immunological adjuvant: enhanced migratory and CD8+ T cell stimulatory capacity of human dendritic cells exposed to leptin. FASEB J. 22, 2012-2022 (2008).
74. Moraes-Vieira P. M. M, et al. Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells. Eur. J. Immunol. 44, 794-806 (2014).
75. Ramirez O, & Garza K. M. Leptin deficiency in vivo enhances the ability of splenic dendritic cells to activate T cells. Int. Immunol. 26, 627-636 (2014).
76. Kimura M, et al. T lymphopenia in obese diabetic (db/db) mice is non-selective and thymus independent. Life Sci. 62, 1243-1250 (1998).
77. Lord G. M, et al. Leptin modulates the T cell immune response and reverses starvation-induced immunosuppression. Nature 394, 897-901 (1998).
78. Sanchez-Margalet V, & Martin-Romero C. Human leptin signaling in human peripheral blood mononuclear cells: activation of the JAK-STAT pathway. Cell. Immunol. 211, 30-36 (2001).
79. De Rosa V, et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 26, 241-255 (2007).
80. Farooqi I. S, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 110, 1093-1103 (2002).
81. Batra A, et al. Leptin: a critical regulator of CD4+ T cell polarization in vitro and in vivo. Endocrinology 151, 56-62 (2010).
82. Kim S. Y, et al. Preferential effects of leptin on CD4 T cells in central and peripheral immune system are critically linked to the expression of leptin receptor. Biochem. Biophys. Res. Commun. 394, 562-568 (2010).
83. Matarese G, Procaccini C, De Rosa V, Horvath T. L, & La Cava A. Regulatory T cells in obesity: the leptin connection. Trends Mol. Med. 16, 247-256 (2010).
84. Cassano S, et al. Leptin modulates autophagy in human CD4+CD25-conventional T cells. Metabolism. 63, 1272-1279 (2014).
85. Procaccini C, et al. Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses. J. Immunol. 189, 2941-2953 (2012).
86. Ma L, et al. Elevated serum leptin levels in patients with systemic lupus erythematosus. Pharmazie 70, 720-723 (2015).
87. Liu Y, Yu Y, Matarese G, & La Cava A. Cutting edge: Fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus. J. Immunol. 188, 2070-2073 (2012).
88. Fujita Y, et al. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp Fas lpr mice. J. Immunol. 192, 979-984 (2014).
89. Margiotta D, et al. Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results. Eur. Rev. Med. Pharmacol. Sci. 20, 636-641 (2016).
90. Yu Y, et al. Cutting edge: Leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus. J. Immunol. 190, 3054-3058 (2013).
91. Deng J, et al. Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response. Arthritis Rheum. 64, 3564-3573 (2012).
92. Reis B. S, et al. Leptin receptor signaling in T cells is required for Th17 differentiation. J. Immunol. 194, 5253-5260 (2015).
93. Busso N, et al. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J. Immunol. 168, 875-882 (2002).
94. Bennett B. D, et al. A role for leptin and its cognate receptor in hematopoiesis. Curr. Biol. 6, 1170-1180 (1996).
95. Claycombe K, King L. E, & Fraker P. J. A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc. Natl Acad. Sci. USA 105, 2017-2021 (2008).
96. Lam Q. L. K, Wang S, Ko O. K. H, Kincade P. W, & Lu L. Leptin signaling maintains B cell homeostasis via induction of Bcl 2 and Cyclin D1. Proc. Natl Acad. Sci. USA 107, 13812-13817 (2010).
97. Agrawal S, Gollapudi S, Su H, & Gupta S. Leptin activates human B cells to secrete TNF α, IL 6, and IL 10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J. Clin. Immunol. 31, 472-478 (2011).
98. Gupta S, Agrawal S, & Gollapudi S. Increased activation and cytokine secretion in B cells stimulated with leptin in aged humans. Immun. Ageing 10, 3 (2013).
99. Tanaka M, et al. Role of central leptin signaling in the starvation-induced alteration of B cell development. J. Neurosci. 31, 8373-8380 (2011).
100. Fujita Y, et al. Prevention of fasting-mediated bone marrow atrophy by leptin administration. Cell. Immunol. 273, 52-58 (2012).
101. Frasca D, et al. Obesity decreases B cell responses in young and elderly individuals. Obesity 24, 615-625 (2016).
102. Scotece M, & Mobasheri A. Leptin in osteoarthritis: focus on articular cartilage and chondrocytes. Life Sci. 140, 75-78 (2015).
103. de Boer T. N, et al. Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthritis Cartilage 20, 846-853 (2012).
104. Figenschau Y, Knutsen G, Shahazeydi S, Johansen O, & Sveinbjörnsson B. Human articular chondrocytes express functional leptin receptors. Biochem. Biophys. Res. Commun. 287, 190-197 (2001).
105. Dumond H, et al. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum. 48, 3118-3129 (2003).
106. Otero M, Gomez Reino J. J, & Gualillo O. Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis Rheum. 48, 404-409 (2003).
107. Conde J, et al. Adipokines and osteoarthritis: novel molecules involved in the pathogenesis and progression of disease. Arthritis 2011, 1-8 (2011).
108. Toussirot E, Streit G, & Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr. Med. Chem. 14, 1095-1100 (2007).
109. Hui W, et al. Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases. Ann. Rheum. Dis. 71, 455-462 (2012).
110. Bao J, et al. Leptin plays a catabolic role on articular cartilage. Mol. Biol. Rep. 37, 3265-3272 (2010).
111. Gómez R, et al. Adiponectin and leptin increase IL 8 production in human chondrocytes. Ann. Rheum. Dis. 70, 2052-2054 (2011).
112. Conde J, et al. Adiponectin and leptin induce VCAM 1 expression in human and murine chondrocytes. PLoS ONE 7, e52533 (2012).
113. Vestweber D. How leukocytes cross the vascular endothelium. Nat. Rev. Immunol. 15, 692-704 (2015).
114. Conde J, et al. Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes. Ann. Rheum. Dis. 70, 551-559 (2011).
115. Conde J, et al. Basic aspects of adipokines in bone metabolism. Clin. Rev. Bone Miner. Metab. 13, 11-19 (2015).
116. Findlay D. M, & Atkins G. J. Osteoblast-chondrocyte interactions in osteoarthritis. Curr. Osteoporos. Rep. 12, 127-134 (2014).
117. Mutabaruka M. S, Aoulad Aissa M, Delalandre A, Lavigne M, & Lajeunesse D. Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Arthritis Res. Ther. 12, R20 (2010).
118. Ducy P, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197-207 (2000).
119. Vuolteenaho K, Koskinen A, Moilanen T, & Moilanen E. Leptin levels are increased and its negative regulators, SOCS 3 and sOb R are decreased in obese patients with osteoarthritis: a link between obesity and osteoarthritis. Ann. Rheum. Dis. 71, 1912-1913 (2012).
120. Koskinen A, Vuolteenaho K, Nieminen R, Moilanen T, & Moilanen E. Leptin enhances MMP 1, MMP 3 and MMP 13 production in human osteoarthritic cartilage and correlates with MMP 1 and MMP 3 in synovial fluid from OA patients. Clin. Exp. Rheumatol. 29, 57-64 (2011).
121. Scotece M, et al. Adipokines induce pro-inflammatory factors in activated CD4+ T cells from osteoarthritis patients. J. Orthop. Res. http://dx.doi.org/10.1002/.jor.23377 (2016).
122. Griffin T. M, Huebner J. L, Kraus V. B, & Guilak F. Extreme obesity due to impaired leptin signaling in mice does not cause knee osteoarthritis. Arthritis Rheum. 60, 2935-2944 (2009).
123. Massengale M, Lu B, Pan J. J, Katz J. N, & Solomon D. H. Adipokine hormones and hand osteoarthritis: radiographic severity and pain. PLoS ONE 7, e47860 (2012).
124. Conde J, et al. Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals. Ann. Rheum. Dis. 73, 631-633 (2014).
125. Zhao X, et al. Leptin changes differentiation fate and induces senescence in chondrogenic progenitor cells. Cell Death Dis. 7, e2188 (2016).
126. Lee S. W, Park M. C, Park Y. B, & Lee S. K. Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol. Int. 27, 537-540 (2007).
127. Targonska-Stepniak B, Majdan M, & Dryglewska M. Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity. Rheumatol. Int. 28, 585-591 (2008).
128. Targonska-Stepniak B, Dryglewska M, & Majdan M. Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis. Rheumatol. Int. 30, 731-737 (2010).
129. Olama S. M, Senna M. K, & Elarman M. Synovial/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. Rheumatol. Int. 32, 683-690 (2012).
130. Xibillé-Friedmann D, Bustos-Bahena C, Hernández-Góngora S, Burgos-Vargas R, & Montiel-Hernández J. L. Two-year follow up of plasma leptin and other cytokines in patients with rheumatoid arthritis. Ann. Rheum. Dis. 69, 930-931 (2010).
131. Paz-Filho G, Mastronardi C. A, & Licinio J. Leptin treatment: facts and expectations. Metabolism. 64, 146-156 (2015).
132. Tchang B. G, Shukla A. P, & Aronne L. J. Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives. Expert Opin. Biol. Ther. 15, 1061-1075 (2015).
133. Matarese G, et al. Selective capacity of metreleptin administration to reconstitute CD4+ T cell number in females with acquired hypoleptinemia. Proc. Natl Acad. Sci. USA 110, E818-E827 (2013).